search icon
      blog search icon

      DSS Stock Surged 5.08% Current-Market, Here’s Why - Stocks Telegraph

      By Iqra Jamal

      Published on

      September 8, 2021

      3:39 PM UTC

      Last Updated on

      September 8, 2021

      3:40 PM UTC

      DSS Stock Surged 5.08% Current-Market, Here’s Why - Stocks Telegraph

      Document Security Systems, Inc. (DSS) is up 5.08% in the current-market trading session at the price of $1.34 after receiving an investment of about $15 million from Alset EHome International. DSS is a multinational company that operates business segments in blockchain security, direct marketing, healthcare, real estate, renewable energy, and consumer packaging. 

      DSS Received a $15 Million Investment from Alset EHome International 

       On 8th September 2021, DSS announced that it had received a $15 million investment from Alset EHome International. The company will issue 12,155,591 shares of its common stock for an aggregate amount of $15 million and a purchase price of $1.234 per share. CEO of DSS, Frank D. Heuszel, remarked that this transaction confirms Alset’s confidence in their company. The mutual alliance with Alset will benefit both companies to accelerate growth moving forward. They work together toward a shared vision of success and a brighter future, he added.  

      Impact BioMedical Synthesized First Quantum-Based Compound 

      On 7th September 2021, Impact BioMedical published that its first Quantum-based compound was synthesized successfully and sent to University for testing. The synthesized compound improves the body’s immune response to a foreign antigen. Research for this project named Quantum initiated by Impact BioMedical and GRDG Sciences in Summer 2020. The purpose was to invent a new frontier by exploring new methods to develop medicinal protocols, encouraging further research and development, and mitigating a projected patent cliff crisis. 

      3FDB “DEET Booster” Technology Displayed Positive Test Results 

       On 23rd August 2021, Impact BioMedical announced encouraging results from the clinical tests of its 3FDB “DEET Booster” technology. The results indicate that 3FDB can boost the effectiveness of mosquito repellants, especially DEET. Director of Scientific Initiatives at GRDG, Daryl Thompson, said that these tests are of great use in addressing mosquito-borne diseases. They could even signal a new frontier of protection strategies, he added. 

      DSS Promoted Todd D. Macko to CFO 

      On 17th August 2021, DSS announced that Todd D. Mackogot had been promoted to Chief Financial Officer. The promotion became effective on 16th August 2021. Mr. Macko is a Certified Public Accountant. He has near 25 years of experience in financial management, corporate strategy, and executive business leadership. Before his role as CFO, Mr. Macko served as Vice President of Finance for DSS. As the VP of Finance, his duties included assisting in in all aspects of financial and regulatory reporting. 

      More From Stocks telegraph